Dow Down1.40% Nasdaq Down1.59%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
14.39 0.64(4.65%) Oct 1, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Assets
Current Assets
Cash And Cash Equivalents91,994  105,257  55,696  67,738  
Short Term Investments44,991  49,665   -   -  
Net Receivables136  195   -  156  
Inventory -   -   -   -  
Other Current Assets1,155  1,245  1,232  3,671  
Total Current Assets 138,276   156,362   56,928   71,565  
Long Term Investments -   -   -   -  
Property Plant and Equipment1,048  538  349  71  
Goodwill3,208  3,208  3,208  3,208  
Intangible Assets -   -   -   -  
Accumulated Amortization -   -   -   -  
Other Assets362  217  281  221  
Deferred Long Term Asset Charges -   -   -   -  
Total Assets 142,894   160,325   60,766   75,065  
Liabilities
Current Liabilities
Accounts Payable18,511  16,369  15,328  16,495  
Short/Current Long Term Debt -   -   -   -  
Other Current Liabilities -   -   -   -  
Total Current Liabilities 18,511   16,369   15,328   16,495  
Long Term Debt -   -   -   -  
Other Liabilities78  41  38   -  
Deferred Long Term Liability Charges -   -   -   -  
Minority Interest -   -   -   -  
Negative Goodwill -   -   -   -  
Total Liabilities 18,589   16,410   15,366   16,495  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -   -  
Redeemable Preferred Stock -   -   -   -  
Preferred Stock -   -   -   -  
Common Stock92  91  83  82  
Retained Earnings(475,284)(452,870)(439,340)(421,672)
Treasury Stock(357)(357)(357)(357)
Capital Surplus599,854  597,051  485,014  480,517  
Other Stockholder Equity -   -   -   -  
Total Stockholder Equity 124,305   143,915   45,400   58,570  
Net Tangible Assets 121,097   140,707   42,192   55,362  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.